TCF4 and hepatocellular carcinoma: It has been shown that antagonists of Tcf4/beta-catenin complex inhibit the growth of HCC cells in vitro and in vivo [58] highlighting the important role of the Wnt/β-catenin-signalling in HCC [59, 60].